Cardiogen is strictly for laboratory research and is commonly employed in the following investigational areas:

Myocardial Tissue Regeneration

Cardiogen is utilized as a chemical probe to investigate the stimulation of cardiomyocyte proliferation in both young and senescent tissue models. Researchers employ this reagent to quantify changes in cell cycle progression and the preservation of myocardial structure following induced stress or injury.

Fibroblast Differentiation and Scarring

In vitro studies utilizing cardiac fibroblasts employ Cardiogen to observe its impact on the balance between functional tissue repair and fibrotic scarring. Investigations focus on how the peptide alters the expression of signaling factors related to differentiation, potentially reducing the formation of non-functional scar tissue.

Apoptosis and Cell Survival

Experimental models utilize this compound to study the regulation of programmed cell death (apoptosis). Researchers quantify changes in p53 protein expression and the activation of anti-apoptotic pathways to understand the role of Cardiogen in preserving cell viability under conditions of oxidative stress or aging.

Oncology and Tumor Metabolism

Cardiogen is used in specific oncology research models, such as M-1 sarcoma, to determine its differential effects on tumor cells versus healthy tissue. Studies investigate the “tumor-modifying” effect, where the peptide may induce apoptosis in transformed cells while protecting normal cardiomyocytes.

Pathway / Mechanistic Context

The primary mechanism of action for Cardiogen in research settings is the modulation of gene expression and protein synthesis via nuclear interaction.

• Nuclear Access: Cardiogen penetrates the cell nucleus and interacts with the nuclear matrix.
• Gene Regulation: It is hypothesized to bind to specific DNA sequences or transcription factors, enhancing the transcription of genes encoding cytoskeletal proteins (actin, vimentin, tubulin) and nuclear lamina (Lamin A/C).
• Resulting Flux: This upregulation supports cellular structural integrity and proliferation in cardiomyocytes, while simultaneously downregulating p53 expression to inhibit pathological apoptosis in aging tissues.

Preclinical Research Summary

Published preclinical literature documents investigations of Cardiogen across multiple experimental models:

• Senescent Tissue: Studies in aged rat models have observed that Cardiogen treatment can stimulate the proliferation of cardiomyocytes and restore cellular metabolism to levels comparable to younger tissues.
• Sarcoma Models: Research utilizing M-1 sarcoma models indicates that Cardiogen may exert a tumor-modifying effect, inducing hemorrhagic necrosis and apoptosis specifically within the tumor mass.
• Cytoskeletal Enhancement: Data from cell culture assays suggest that incubation with Cardiogen leads to a significant increase in the synthesis of key structural proteins, indicating an enhanced capacity for cellular repair and maintenance.

Form & Analytical Testing

This material is produced via robust chemical synthesis and supplied as a lyophilized (freeze-dried) powder.

• Lyophilization: Removes water content under vacuum to maintain compound integrity and extend shelf-life.
• Identity Verification: Each lot undergoes Mass Spectrometry (MS) to confirm molecular weight and identity.
• Purity Verification: High-Performance Liquid Chromatography (HPLC) is performed to ensure the product meets the ≥99% purity standard required for reproducible research data.

Referenced Citations

References are provided for informational purposes only and are not clinical claims.

• Ni, C., et al. (2009). The effect of the amino acids and cardiogen on the development of myocard tissue culture from young and old rats. Advances in Gerontology, 22(3), 409–413. https://pubmed.ncbi.nlm.nih.gov/20210190/
• Levdik, N., & Knyazkin, I. (2009). Tumor-Modifying Effect of Cardiogen Peptide on M-1 Sarcoma in Senescent Rats. Bulletin of Experimental Biology and Medicine, 148(3), 433–436. https://doi.org/10.1007/s10517-010-0730-9
• Kheifets, O., Poliakova, V., & Kvetnoi, I. (2010). Peptidergic regulation of the expression of signal factors of fibroblast differentiation in the human prostate gland in cell aging. Advances in Gerontology, 23(1), 68–70. https://pubmed.ncbi.nlm.nih.gov/20586252/

• Stable at room temperature for up to 90 days. For long-term storage, keep at -20°C (-4°F) or colder.
• Once mixed with a solvent (e.g., bacteriostatic water), the solution must be stored at 4 °C (39°F) and utilized within 30 days. Avoid repeated freeze-thaw cycles, as this degrades the peptide structure.

RESEARCH USE ONLY

This product is intended strictly for laboratory research use only. It is not for human or veterinary use. It is not intended for diagnosis, treatment, cure, or prevention of any disease. All purchases are subject to our Terms of Service and Purity Guarantee.

No COAs available for this product.